How Immune Cells Called Tregs Help Repair Damaged Tissues
Control of Regulatory T Cell Function by Toll-Like Receptor 7
This project explores how special immune cells, called Tregs, receive signals to help heal damaged body tissues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-11121732 on NIH RePORTER |
What this research studies
Our bodies have special immune cells called Regulatory T cells (Tregs) that not only control our immune system but also play a vital role in repairing tissues after injury. This work focuses on understanding the specific signals that tell these Tregs to start their repair functions, particularly looking at a sensor on their surface called Toll-like receptor 7 (TLR7). We believe that TLR7 helps Tregs detect damaged tissue and then produce important healing factors, such as amphiregulin. By studying this process in both laboratory models and human cells, we aim to uncover how to encourage these cells to better repair tissues. This deeper understanding could pave the way for new strategies to boost the body's natural healing abilities.
Who could benefit from this research
Good fit: This foundational research does not directly involve patient participation, but future studies based on this work might seek patients with conditions involving tissue damage or impaired healing.
Not a fit: Patients seeking immediate treatment options would not directly benefit from this basic science project.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that enhance the body's natural ability to repair damaged tissues by targeting specific immune cells.
How similar studies have performed: While the general role of Tregs in immune regulation is well-established, the specific signals that instruct their tissue repair functions, particularly involving TLR7, are a novel area of investigation.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Barton, Gregory M — University of California Berkeley
- Study coordinator: Barton, Gregory M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.